Chemours (CC) Capital Expenditures (2014 - 2026)

Chemours' Capital Expenditures history runs 13 years deep, the most recent figure standing at -$17.0 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 165.38% year-over-year to -$17.0 million in Q1 2026; TTM through Mar 2026 was -$10.0 million, a 183.33% decrease from a year earlier, with the FY2025 full-year figure at $33.0 million, down 62.5% from the prior year.
• Capital Expenditures advanced to -$17.0 million in Q1 2026 per CC's latest filing, from -$135.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $429.0 million in Q4 2023 and bottomed at -$208.0 million in Q3 2023.
• The 5-year median for Capital Expenditures is $34.0 million (2023), against an average of $45.9 million.
• Biggest YoY gain for Capital Expenditures was 2775.0% in 2023; the steepest drop was 20900.0% in 2023.
• Year by year, Capital Expenditures stood at $265.0 million in 2022, then jumped by 61.89% to $429.0 million in 2023, then slumped by 68.3% to $136.0 million in 2024, then tumbled by 199.26% to -$135.0 million in 2025, then jumped by 87.41% to -$17.0 million in 2026.
• Per Business Quant, the three latest CC Capital Expenditures figures stand at -$17.0 million (Q1 2026), -$135.0 million (Q4 2025), and $41.0 million (Q3 2025).